Valve-like tissues may mimic inflammatory disease

Stem cell–derived tissues showed enhanced maturation and developed calcification-associated changes consistent with diseased human valve samples.

Category	Detail
Condition	Inflammatory Heart Valve Disease
Key Mechanisms	Three-dimensional heart valve-like tissues generated from human pluripotent stem cells show enhanced maturation and reproduce features of inflammatory heart valve disease.
Target Population	Individuals with inflammatory heart valve disease.
Care Setting	Experimental platform for investigating human valve development and disease.

85% of cells expressed valve interstitial cell lineage marker SOX9 after 15 days.
MacroVETs showed a more mature valve-like molecular profile compared to 2D cultures.
Cytokine stimulation in microVETs increased markers associated with tissue calcification.
MacroVETs demonstrated no evidence of degradation or calcification at 7 or 30 days post-implantation in rats.
VETs provide a platform for drug discovery and understanding valve disease pathogenesis.

Utilize proteomic and transcriptomic analyses to identify disease-associated proteins and genes.

Further develop biomechanical properties of VETs for potential use as replacement valves.

Assess safety, durability, and functional efficacy of VETs in long-term studies.

MacroVETs exhibited inferior biomechanical properties compared to human aortic valves.

Patients with inflammatory heart valve disease.

VETs may serve as a basis for future development of replacement valves derived from human induced pluripotent stem cells.

Incorporate mechanical stress and hormonal cues to enhance postnatal valve maturation in engineered tissues.
Utilize microVETs for disease modeling and drug screening.